Joanna Gajuk
Stock Analyst at B of A Securities
(1.89)
# 1,733
Out of 4,417 analysts
14
Total ratings
83.33%
Success rate
22.09%
Average return
Main Sectors:
9 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Initiates: Buy | $14 | $11.50 | +21.74% | 1 | Feb 20, 2024 | |
| BKD Brookdale Senior Living | Upgrades: Neutral | $3.95 → $6 | $7.49 | -19.89% | 1 | Dec 15, 2023 | |
| AHCO AdaptHealth | Maintains: Neutral | $13 → $11 | $10.26 | +7.21% | 2 | Sep 22, 2023 | |
| USPH U.S. Physical Therapy | Initiates: Buy | $138 | $105.20 | +31.18% | 1 | Jun 30, 2023 | |
| EHAB Enhabit | Initiates: Underperform | $16 | $10.18 | +57.17% | 1 | Jul 13, 2022 | |
| AMED Amedisys | Downgrades: Underperform | $145 → $102 | $92.43 | +10.35% | 5 | Jun 21, 2022 | |
| ADUS Addus HomeCare | Initiates: Buy | $110 | $98.20 | +12.02% | 1 | Apr 13, 2022 | |
| AVAH Aveanna Healthcare Holdings | Downgrades: Neutral | $10 → $5.5 | $2.33 | +136.05% | 1 | Mar 29, 2022 | |
| SCI Service Corporation International | Maintains: Buy | n/a | $67.59 | - | 1 | Feb 21, 2018 |
BrightSpring Health Services
Feb 20, 2024
Initiates: Buy
Price Target: $14
Current: $11.50
Upside: +21.74%
Brookdale Senior Living
Dec 15, 2023
Upgrades: Neutral
Price Target: $3.95 → $6
Current: $7.49
Upside: -19.89%
AdaptHealth
Sep 22, 2023
Maintains: Neutral
Price Target: $13 → $11
Current: $10.26
Upside: +7.21%
U.S. Physical Therapy
Jun 30, 2023
Initiates: Buy
Price Target: $138
Current: $105.20
Upside: +31.18%
Enhabit
Jul 13, 2022
Initiates: Underperform
Price Target: $16
Current: $10.18
Upside: +57.17%
Amedisys
Jun 21, 2022
Downgrades: Underperform
Price Target: $145 → $102
Current: $92.43
Upside: +10.35%
Addus HomeCare
Apr 13, 2022
Initiates: Buy
Price Target: $110
Current: $98.20
Upside: +12.02%
Aveanna Healthcare Holdings
Mar 29, 2022
Downgrades: Neutral
Price Target: $10 → $5.5
Current: $2.33
Upside: +136.05%
Service Corporation International
Feb 21, 2018
Maintains: Buy
Price Target: n/a
Current: $67.59
Upside: -